Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants With End-Stage Kidney Disease on Hemodialysis
Clinical trial NCT07759167 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07759167
- Sponsor
- Regeneron Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-09
- Primary completion
- 2027-03-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.